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Abstract
Background: Previous studies investigating the role of cytokines in the pathogenesis of leprosy have either been on only
small numbers of patients or have not combined clinical and histological data. The INFIR Cohort study is a prospective study
of 303 new multibacillary leprosy patients to identify risk factors for reaction and nerve damage. This study characterised
the cellular infiltrate in skin and nerve biopsies using light microscopic and immunohistochemical techniques to identify any
association of cytokine markers, nerve and cell markers with leprosy reactions.
Methodology/Principal Findings: TNF-a, TGF-b and iNOS protein in skin and nerve biopsies were detected using
monoclonal antibody detection immunohistochemistry techniques in 299 skin biopsies and 68 nerve biopsies taken from
patients at recruitment. The tissues were stained with hematoxylin and eosin, modified Fite Faraco, CD68 macrophage cell
marker and S100.
Conclusions/Significance: Histological analysis of the biopsies showed that 43% had borderline tuberculoid (BT) leprosy,
27% borderline lepromatous leprosy, 9% lepromatous leprosy, 13% indeterminate leprosy types and 7% had no
inflammation. Forty-six percent had histological evidence of a Type 1 Reaction (T1R) and 10% of Erythema Nodosum
Leprosum. TNF-a was detected in 78% of skin biopsies (181/232), iNOS in 78% and TGF-b in 94%. All three molecules were
detected at higher levels in patients with BT leprosy. TNF-a was localised within macrophages and epithelioid cells in the
granuloma, in the epidermis and in dermal nerves in a few cases. TNF-a, iNOS and TGF-b were all significantly associated
with T1R (p,0.001). Sixty-eight nerve biopsies were analysed. CD68, TNF-a and iNOS staining were detectable in 88%, 38%
and 28% of the biopsies respectively. The three cytokines TNF-a, iNOS and TGF-b detected by immunohistochemistry
showed a significant association with the presence of skin reaction. This study is the first to demonstrate an association of
iNOS and TGF-b with T1R.
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Introduction
Leprosy is complicated by leprosy reactions and the develop-
ment of nerve damage. These are immune mediated events and
may occur before diagnosis, during and after anti-bacterial multi
drug treatment [1]. Understanding the pathology of these episodes
and identifying risk factors for them is important for developing
strategies to reduce nerve damage.
The ILEP Nerve Function Impairment in Reactions (INFIR) is
a prospective cohort study comprised of 303 new multibacillary
(MB) leprosy patients from North India who were recruited to
study risk factors for reactions and nerve damage in leprosy [2].
After recruitment they were assessed monthly for a year and then
every two months until 24 months. They had detailed clinical and
comprehensive neurological examinations and blood was taken
at every visit. Skin biopsies were taken from all patients at
recruitment and then again if they developed a Type 1 Reaction
(T1R). Nerve biopsies were taken when patients had evidence of
acute nerve function impairment. Inclusion criteria for the study
allowed recruitment of patients with reactions and new nerve
damage enabling us to compare patients with and without
reactions. Linking clinical, histological and immunological data
on patients enables us to test whether particular cytokines or cell
types were markers for nerve damage and reactions. It also
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allowed us to make a comprehensive assessment of the pathology
of leprosy lesions as seen in this cohort at baseline. We were also
able to compare the histological features of leprosy pathology
in skin and nerve. Previous publications from this cohort have
reported on the clinical features of nerve damage and clinical
markers for reactions [2,3].
The immunopathology underlying T1R is increased cell
mediated immunity with CD4 and macrophage cell activation
with production of the Th1-type cytokines interferon-gamma
(IFN-c), interleukin-2 (IL-2) and interleukin-12 (IL-12) [4]. The
immunopathology underlying Erythema Nodosum Leprosum
(ENL) is that of an antigen-antibody mediated vasculitis [5]. We
studied a panel of cytokines and markers that previous small
studies have shown to be associated with the pathology of T1R,
Tumour Necrosis Factor alpha (TNF-a), inducible Nitric Oxide
Synthase (iNOS) and Transforming Growth Factor beta (TGF-b).
Macrophages were located using a CD68 marker and S100
staining was used to assess nerve fibre integrity.
The pro-inflammatory cytokine TNF-a is crucial to anti-
mycobacterial immunity and plays an important role in granulo-
ma formation during mycobacterial infection [6,7,8,9,10]. TNF-a
protein has been detected in skin lesions across the leprosy
spectrum with greater production of TNF-a in lesions from
tuberculoid leprosy (TT) patients in whom granuloma formation is
better and few or no mycobacteria are detectable. However, excess
TNF-a can cause tissue damage in diseases such as rheumatoid
arthritis and inflammatory bowel disease, and thus this cytokine
plays a key role in tissue damage in leprosy. TNF-a protein has
been detected in biopsies taken from leprosy patients with skin
reactional lesions, both T1R and ENL [10,11,12]. A study in
Indian patients found that a higher percentage of cells producing
mRNA and protein for TNF-a were found in skin and nerve
biopsies with T1R lesions when compared with biopsies from non-
reactional borderline tuberculoid (BT) or borderline lepromatous
(BL) skin lesions [13,14]. We therefore hypothesised that high
TNF-a production might be a key part of the pathological process
of leprosy reactions; then finding high levels of TNF-a in skin
biopsies might be a marker for leprosy reactions.
iNOS is an enzyme responsible for synthesis of reactive nitrogen
radicals involved in killing of mycobacteria [8]. Expression of
iNOS is associated with bacterial killing and a previous study done
in India showed high levels in skin lesions of TT and absence in
lepromatous leprosy (LL) [15]. High levels of iNOS have also been
found in skin biopsies from leprosy patients experiencing T1R in
both India and Ethiopia [4,16]. Increased level of iNOS in T1R
are consistent with an immunological model in which patients
moving towards the tuberculoid end of the spectrum have increased
cell mediated immunity and enhanced intracellular killing capacity
of macrophages [15]. A study in Ethiopian patients showed
that iNOS was found to be associated with dermal nerves in the
granulomas of BL leprosy and might have a role in nerve damage.
We therefore hypothesised that a marker for T1R would be
increased iNOS in the skin and nerve lesions of patients.
TGF-b is a multifunctional cytokine and, depending on the
environment and concentration, has both pro- and anti-inflammatory
properties [17,18]. TGF-b induces wound healing by chemoattraction
of monocytes and leukocytes, induction of angiogenesis and control of
inflammatory mediators. The anti-inflammatory effects of TGF-b
include antagonism of T cell proliferation [19] and IFN-c, TNF-a and
iNOS production [20,21]. Immunohistochemical studies have showed
that active TGF-b1 is present in skin lesions throughout the leprosy
spectrum, though in greatest abundance in LL [15]. Accumulation of
TGF-b1 in lepromatous lesions may play a role in the absence of
iNOS. Levels of active TGF-b1 are low in T1R compared to non-
reactional BT/BL skin and hence may be an important factor
contributing to the unregulated inflammatory process.
The location and distribution of CD4 and CD8 cells in leprosy
lesions have been well described; tuberculoid lesions have abundant
T cells in the granuloma of a CD4 lineage, fewer T cells are found in
the LL skin lesions and they have a higher proportion of CD8 cells
[22]. The CD4 cells in tuberculoid lesions also have a typical
location with CD4 cells in the central area and a rim-like mantle of
CD8 cells. In lepromatous lesions CD8 cells are admixed with
macrophages and CD4 cells [23]. Narayanan et al described the
distribution of T cells in leprosy reactional lesions [24]. Although
macrophages are a key cell in the leprosy granuloma, only one small
study has looked at the distribution of macrophages in leprosy
reactional skin lesions and high numbers of CD68 cells were found
in T1R lesions [13]. There has been no systematic study of the
distribution of CD68 cells in lesions across the spectrum and
comparing the distribution in reactional and non-reactional skin
lesions.
S100 is a specific nerve tissue protein and can be stained for
histologically [25]. Several studies have demonstrated and
described the utility of S100 staining as an aid to visualise dermal
nerves, and to assess their morphology and nerve damage [26].
We added S100 staining to our panel of markers to aid assessing
the morphology of nerves.
Previous pathological studies have been done on small groups of
patients, often with poorly described case definitions. This large
cohort study is the first large field based study to include
pathological investigations in the assessments. The adequate
sample size allows us to compare the different types of leprosy
and to test for the effect of various factors relating to leprosy
reactions.
Previous studies reported that the pathology of leprosy in nerve
biopsies is often more severe than that of skin lesions, with a
heavier bacterial load and more inflammation in nerves. We tested
the following hypotheses in relation to identifying cytokines and
proteins as markers for reactions and leprosy nerve damage in
both skin and nerve biopsies taken in this cohort:
1.TNF-a levels would be higher in reactional lesions
2. iNOS levels would be higher in reactional lesions
3.TGF-b levels would be reduced in reactional lesions
Author Summary
Leprosy affects skin and peripheral nerves. Although we
have effective antibiotics to treat the mycobacterial
infection, a key part of the disease process is the
accompanying inflammation. This can worsen after start-
ing antibacterial treatment with episodes of immune
mediated inflammation, so called ‘reactions’. These reac-
tions are associated with worsening of the nerve damage.
We recruited a cohort of 303 newly diagnosed leprosy
patients in North India with the aim of understanding and
defining the pathological processes better. We took skin
and nerve biopsies from patients and examined them to
define which molecules and mediators of inflammation
were present. We found high levels of the cytokines
Tumour Necrosis Factor alpha, Transforming Growth
Factor beta and inducible Nitric Oxide Synthase in biopsies
from patients with reactions. We also found high levels of
bacteria and inflammation in the nerves. These experi-
ments tell us that we need to determine which other
molecules are present and to explore ways of switching off
the production of these pro-inflammatory molecules.
Cytokines in Leprosy Reactional Skin and Nerve
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4.Nerve lesions would have a more severe pathology than skin
lesions with more inflammation.
Methods
Ethical considerations
The study was approved by the ethics committee of the Central
JALMA Institute for Leprosy, a major leprosy research centre of
the Indian Council for Medical Research. No financial incentives
were given to participants. Informed written consent was obtained
from individual study subjects before inclusion in the study, using a
standard consent form. Further details are available elsewhere [2].
Design
This was a cohort study of 303 newly registered MB patients.
The patients were followed up monthly for one year and every
second month during the second year.
Location
Recruitment of subjects took place in The Leprosy Mission
(TLM) hospitals in Naini and Faizabad, specialist leprosy referral
centres in Uttar Pradesh, North India. The immunological and
histopathological investigations were carried out at the LEPRA
Society Blue Peter Research Centre in Hyderabad, Andhra
Pradesh and at the TLM Stanley Brown Laboratories formerly
located in Miraj, Maharashtra now in Shahdra, New Delhi.
Study population
The study population comprised newly registered MB patients
requiring a full course of multi drug therapy. A detailed
description of the study design has already been published [27].
Definitions
Nerve function assessment: Nerve function impairment
was present when a patient had either or both motor or sensory
loss which were assessed by voluntary muscle testing and with
Semmes-Weinstein monofilaments as described previously [2].
Nerve function impairment was categorised as old when signs and
symptoms had been present for more than six months and new
when signs and symptoms had been present for six months or less.
Type 1 or Reversal Reaction: T1R was diagnosed when a
patient had erythema and oedema of skin lesions. This may have
been accompanied by neuritis and oedema of the hands, feet and
face. A patient could have a skin reaction only, a nerve reaction
only, or a skin and nerve reaction. Figure 1 shows a typical skin
reaction lesion.
Figure 1. Patient with borderline tuberculoid leprosy face lesion with severe Type 1 Reaction. Facial patch in severe Type1 Reaction with
erythema and oedema of the lesion and mild scaling.
doi:10.1371/journal.pntd.0001327.g001
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Erythema Nodosum Leprosum: ENL was diagnosed when
a patient had crops of tender subcutaneous skin lesions. There may
have been accompanying neuritis, iritis, arthritis, orchitis,
dactylitis, lymph-adenopathy, oedema and fever.
Database
All the data obtained in the study, including the clinical,
neurophysiological, serological and histopathological, were en-
tered on a computer locally and subsequently merged into a single
Microsoft Access database. Further details of the study, methods,
definitions, documentation and the status of the cohort at baseline
have been published [2].
Skin biopsies
All patients had an elliptical incision skin biopsy taken from an
active skin lesion at enrolment.
Nerve biopsies
These were done when patients had evidence of acute neuritis.
A partial thickness biopsy was taken from a palpable regional
cutaneous nerve. The biopsies were split in half, and one portion
was fixed in 10% buffered formal saline and the other snap frozen
in liquid nitrogen. The biopsies were transported in liquid nitrogen
or formalin to the Blue Peter Research Centre, Hyderabad for
processing and analysis.
Biopsy processing
The skin and nerve biopsies were processed and embedded in
paraffin and serially sectioned in the saggital plane at 5 m thickness
on a Leica microtome. Sections were stained with Haematoxylin
and Eosin (H&E) stain to study morphology and modified Fite-
Faraco to identify acid fast bacilli. Acid fast bacilli was graded
according to Ridley’s scale of 0 to 6+ as Bacillary Index of
Granuloma.
Biopsy assessments
The biopsy assessments were done using a standardised set of
definitions for histological features and recorded on a proforma. A
single pathologist (SS) reviewed the H&E and Fite Faraco stained
sections and assessed the diagnosis of leprosy, assigned each case a
Ridley-Jopling classification and assessed the presence of leprosy
reaction and neuritis.
Skin biopsy
Diagnosis of leprosy. This was confirmed when evidence of
nerve inflammation and/or acid fast bacilli were seen and a
granulomatous inflammation consistent with leprosy was present
[28]. The following morphological features were assessed on all
sections:
1.Cellular infiltrate/granuloma: The assessment of the
cellular infiltrate consisted of identifying granuloma formation,
type, population and maturity of the cells making up the
granuloma and the fraction of the dermis occupied by the
infiltrate (interpreted as granuloma fraction).
2.Oedema: This was present in dilated vascular channels
(capillaries and lymphatics), causing splaying out of the dermal
collagen. Extra cellular oedema was present when wide
separation of cellular infiltrate was present and intracellular
oedema when ballooning of individual cells was seen.
3.Nerve inflammation: This was graded as perineural
inflammation when the inflammatory cells were present
around the nerve and intraneural inflammation when the
inflammatory cells were found inside a nerve.
4.Necrosis: This was reported as present when caseous necrotic
foci and apoptotic cells were seen in the infiltrate.
5.Bacterial Index of Granuloma: This was graded from 0 to
6+ based on Ridley’s scale.
6.Ridley-Jopling Classification: This was used in the
diagnosis of leprosy patients.
Table 1. Ridley-Jopling classification, Bacterial Index and Granuloma Fraction for skin biopsies.
Bacterial Index Granuloma Fraction
R-J classification n (%) Mean SD Mean SD
Borderline tuberculoid (BT) 128 (42.6) .2 .4 25.8 14.0.
Borderline lepromatous (BL) 82 (27.5) 2.8 1.6 22.9 13.0.
Lepromatous leprosy (LL) 28 (9.4) 4.2 1.3 27.9 18.9
Indeterminate leprosy 39 (13.1) 0 0 7.3 2.8
No significant lesions (NSL) 22 (7.4) 0 0 5.7 2.3
Total 299 1.2 1.8
doi:10.1371/journal.pntd.0001327.t001
Table 2. Classification of patients by Ridley-Jopling and
reaction types.
Ridley-Jopling type N (%) Reaction categories
Borderline
tuberculoid (BT) 128 (53.6)
BT 61(48%)
BT in T1R* 67 (52%)
Borderline
lepromatous (BL)
82 (34.6) BL 47 (57.3%)
BL in T1R 33 (40.2%)
BL in ENL** 2 (2.4%)
Lepromatous
leprosy (LL)
28 (11.8) LL 20 (71.4%)
LL in ENL 8 (28.6%)
Totals 238 238
*T1R: Type 1 Reactions.
**ENL: Erythema Nodosum Leprosum.
doi:10.1371/journal.pntd.0001327.t002
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Lepromatous leprosy (LL). When macrophage and foam
cell collections present with numerous bacilli interspersed with
sparse number of lymphocytes.
Borderline lepromatous (BL) leprosy. When there were
macrophage granulomas, numerous lymphocytes and moderate
numbers of bacilli.
Borderline tuberculoid (BT) leprosy. When lympho-
epithelioid granuloma presents with occasional Langhans giant cells.
Tuberculoid leprosy (TT). When immature epithelioid cells
are present together with Langhans giant cells and numerous
lymphocytes.
Indeterminate leprosy. When some nerve inflammation is
seen with rare acid fast bacilli and an absence of clear epithelioid
or macrophage granulomas.
Non-specific inflammation. Used as a diagnostic category
when inflammation was present without the specific features for
leprosy, notably neural inflammation and acid fast bacilli.
Type 1 Reaction (T1R). When at least two of the following
features were present: granulomas with extra and intracellular
oedema, dilated vascular channels, separation of dermal collagen,
evidence of an intense delayed-type hypersensitivity (DTH) response
with acute damage to dermal nerves and granuloma [29].
ENL reaction. When a polymorphonuclear neutrophilic infil-
trate on the background of a macrophage granuloma accompanied by
oedema and often with evidence of vasculitis and/or panniculitis was
seen [30].
Nerve biopsy
Nerve biopsy sections were reviewed using the same criteria and
graded into Ridley-Jopling classes.
Borderline tuberculoid (BT) leprosy. When the nerve was
infiltrated by multiple collections of epithelioid cells, giant cells and
focal aggregates of lymphocytes.
Borderline lepromatous (BL) leprosy. When there were
sheets of macrophages with acid fast bacilli interspersed with
lymphocytes and a few plasma cells.
Lepromatous leprosy (LL). When numerous bacilli in
Schwann cells and relatively few intraneural inflammatory cells
were present.
Indeterminate leprosy. When a mild lymphohistiocytic
infiltrate with a rare acid fast bacilli was present.
Neuritis and T1R in nerve. When there was oedema in the
nerve with wide separation of the axons and an increased
population of inflammatory cells.
Figure 2. Skin borderline tuberculoid leprosy in Type 1 Reaction. Skin - BT in Type 1 Reaction showing aggressive epithelioid granuloma,
epidermal erosion, extracellular oedema and lymphocytic influx. H&E staining620.
doi:10.1371/journal.pntd.0001327.g002
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Validation of histological diagnosis
A purposely selected sample of 68 slides was sent to a second
pathologist who used the same scoring system for diagnosis of
leprosy and reactions. The selection covered the full range of
leprosy types and reactions. The paired assessments made by SS
and by an independent assessor blinded to the assessment by SS
were compared. There was perfect or good agreement on the
Ridley-Jopling classification in all 51 biopsies (this excludes
biopsies that showed non-specific inflammation). For the bacterial
index assessment the Kappa was 0.5 and for the granuloma
fraction assessment the kappa was 0.6 indicating good agreement.
SS diagnosed T1R in 20/66 biopsies and MJ in 11/66. There
were four T1R diagnosed by MJ but not SS and 13 diagnosed by
SS but not MJ. Comparing the ENL diagnoses showed that SS
diagnosed 6/66 as having ENL and MJ 4/66. They only agreed
on one ENL diagnosis.
Immunohistochemical staining
Sections were mounted on Poly-L-Lysine (BDH, Poole, UK)
coated slides. They were stained using the following series of
incubations and washes: xylene - 10 minutes, two changes; 100%
ethanol - 5 minutes, two changes; 70% ethanol - 5 minutes and
50% ethanol - 5 minutes. Endogenous peroxidase activity was
quenched with 0.06% hydrogen peroxide in absolute methanol for
10 minutes and then rinsed in distilled water. The sections were
incubated with trypsin at a concentration of 1 mg/ml for
30 minutes at 37uC in 0.1 mM CaCl2. Monoclonal antibodies to
TNF-a (Monosan 5006, Monosan), CD68 (M0876, DAKO,
Denmark) and iNOS (610328, BD Transduction Laboratories,
USA) and polyclonal antibodies to S100 (Z0311, DAKO,
Denmark) and TGF-a (sc-146, Santa Cruz Biotechnology Inc.,
USA) were used to detect epitope immunoreactivity in paraffin
sections of skin and nerve biopsies of leprosy patients. Standard-
isation of incubation times and antibody concentrations was
carried out.
The immunohistochemical technique involved the sequential
application of the following reagents in a humidified chamber:
blocking with normal rabbit sera 1:10 (for monoclonal antibodies)
and normal swine sera 1:10 (for polyclonal antibodies) in
phosphate buffered saline for 30 minutes followed by incuba-
tion with the monoclonal antibodies CD68, TNF-a, iNOS and
polyclonal antibodies TGF-a and S-100 at optimized concentra-
tions in phosphate buffered saline containing 1% bovine serum
albumen, for 1 hour at room temperature. A secondary biotiny-
lated rabbit/swine anti-antibody diluted in blocking buffer (1:250)
was interacted with the sections for 30 minutes. This step was
Figure 3. Delayed-type hypersensitivity in dermal nerve. Skin - BT in Type 1 Reaction showing aggressive DTH with epithelioid granuloma
destroying a deep dermal nerve, areas of necrosis and focal lymphocytic response. H&E staining620.
doi:10.1371/journal.pntd.0001327.g003
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followed by incubation with Avidin Biotin complexed horse radish
peroxidase (K 0377, DAKO, Denmark) for 30 minutes. Each
incubation step was followed by washing the tissue sections in
phosphate buffered saline twice (5 minutes each). The controls for
the specificity of staining included using normal serum, omitting
the primary antibody, and using similar isotype antibodies.
The sites of immunocomplex were identified by light micros-
copy following treatment with a chromogen, 39 diamino benzidine
tetrachloride. Further, the sections were counter-stained with
Harris’ haematoxylin for 2 minutes, mounted in DPX mountant
and were visualized by an Olympus BX.50 microscope. The
Olympus PM-30 exposure control unit was used for micropho-
tography.
The immunohistochemical stained sections were assessed and
graded by a pathologist (SS) and three investigators (LS, KS, MC)
with regular crosschecking of the process.
The cell and cytokine staining was assessed by grading the
sections with the following scale: 0, negative; 1+, a few scattered
positive cells; 2+, 10–30% of the cells were positively stained; 3+,
30–50% of the cells were positively stained; 4+, 50–80% of the
cells were positively stained; and 5+, 80–100% of the cells were
positively stained. Cellular infiltration was assessed with the
following scale: 0+, no cellular infiltrate; 1+, groups of cells; 2+,
moderate cellular infiltration; and 3+, extensive cellular infiltra-
tion. This scale has been used in previous work [18,20,23]. For a
small number of biopsies the full set of assessments was not
completed. This accounts for the variability in numbers in some
tables.
Statistical analysis
To assess the association between these staining groups and
variables describing reaction status or Ridley-Jopling classification
we used Pearson’s chi-squared test.
Patients at risk of developing T1R. A sub group of patients
at risk of developing T1R was identified. This excluded patients
with ENL and the patients with no significant lesions (NSL).
Patients with ENL were excluded because they were very unlikely
to have T1R and ENL simultaneously at baseline. Patients with
NSL were excluded in this analysis because the comparison
involved a histological comparison and their biopsy showed so
little inflammation that assessing the histological features of
reaction was not possible.
Results
Two hundred and ninety-nine skin biopsies were available for
morphological and immunohistochemical assessment. Table 1
gives the Ridley-Jopling classification of skin biopsies by
histological assessment. One hundred and twenty-eight biopsies
Table 3. Immuno-staining in skin biopsies for CD68, TNF-a, TGF-b and iNOS.*
BT** BL*** LL{ No RR{ RR ENL1
Level of StainingI % (N=128) % (N=82) % (N=28) % (N=152) % (N=113) % (N=13)
CD68 0 4.7 4.9 3.6 8.6 4.4 7.7
1 25.0 30.5 10.7 43.4 14.2 15.4
2 49.2 45.1 57.0 39.5 50.4 53.8
3 19.5 14.6 21.4 7.2 26.6 15.4
4 1.6 4.9 7.1 1.3 4.4 7.7
TNF-a 0 17.3 28.8 26.9 36.9 12.6 7.7
1 42.5 31.3 38.5 43.0 28.8 38.4
2 26.8 26.3 26.9 16.1 36.9 46.2
3 6.3 13.8 7.7 4.0 13.5 7.7
4 7.1 0.0 0.0 0.0 8.1 0.0
TGF-b 0 6.3 6.1 0.0 9.9 4.5 0.0
1 20.5 32.9 25.0 47.4 8.0 30.7
2 39.4 40.2 25.0 31.6 42.9 15.4
3 26.0 15.9 39.3 9.2 33.0 46.2
4 7.9 4.9 10.7 2.0 11.6 7.7
iNOS 0 21.9 23.5 14.3 31.1 16.8 0.0
1 27.3 35.8 32.1 37.8 25.7 46.2
2 38.3 37.0 53.6 29.8 42.5 53.8
3 12.5 3.7 0.0 1.3 15.0 0.0
4 0.0 0.0 0.0 0.0 0.0 0.0






IThe following molecules were assessed as marker for TIR in skin biopsies: CD68+ (sensitivity 82%, specificity 52%), TNF-a (sensitivity 59%, specificity 80%), iNOS
(sensitivity 58%, specificity 69%) and TGF-b (sensitivity 88%, specificity 57%).
doi:10.1371/journal.pntd.0001327.t003
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were diagnosed as showing BT; 82 as BL; 28 as LL; 22 as NSL;
and 39 as indeterminate.
BT and BL groups were then further classified by the presence
or absence histologically of T1R giving 61 BT and 67 BT T1R
biopsies and 47 BL and 33 BL T1R biopsies (Table 2). This total
of 208 biopsies excludes two BL cases with histological ENL.
Among these the biopsies classified as showing evidence of a T1R
all had typical features of T1R with prominent oedema and other
changes (Figures 2 and 3).
There were 28 LL patients of whom eight had evidence of ENL.
Two BL patients with biopsy evidence of ENL were also added to
this group to give a total of 10 biopsies in the ENL group.
The biopsies in this cohort were assigned to different groups for
the purposes of analysis and this grouping was used consistently
throughout the analysis. The indeterminate/NSL group were
considered separately from the main Ridley-Jopling groups. The
main comparisons for association of the presence of T1R in the
skin biopsy were done on the combined BT and BL group.
Morphological analysis
Many of the BT case biopsies showed pronounced inflammation
(Figures 2 and 3). In the biopsies showing features of T1R, dilated
vascular channels, wide separation and paleness of the collagen
connective tissue and intra- and extracellular oedema were present
as the key histological features. The cellular infiltrate in these
biopsies diagnosed with T1R included Langhans and multinucle-
ate giant cells together with lymphocytes. There was a strong,
significant association between granuloma fraction and T1R
(p,0.01).
Immunostaining
The level of immunostaining for CD68, TNF-a, TGF-b and
iNOS in the different leprosy types and by reaction status are
summarised in Table 3.
CD68. CD68+ cells were detected in 95% skin biopsies
(Figure 4) from 210 BT and BL cases judged to be at risk of reverse
reactions at baseline (Table 3). Cells were located in granulomas
(95% biopsies) and dermis (45–59% biopsies). There were low
levels of CD68+ cells in the biopsies from the indeterminate/ NSL
group with 64% of this group showing grade 1 and 11% grade 2.
In this group the cells were located in the dermis and granuloma
and none in the dermal nerves. CD68+ staining was significantly
higher in biopsies from patients with T1R status (p,0.001) and
this association was only present for the BT patients (p,0.001). BL
patients had similar levels of CD68+ cells whether or not they were
in reaction. CD68+ cells were found principally in the reactional
granuloma (95%) and some in the dermis (40%) and the reactional
biopsies had significantly fewer CD68+ cells than the non-
Figure 4. Skin showing CD68 cells. Skin showing CD68 positive macrophages. IHC staining640.
doi:10.1371/journal.pntd.0001327.g004
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reactional biopsies (p,0.001). Almost no CD68+ cells were found
in the epidermis or dermal nerves for both reactional and non-
reactional cases. Nearly all biopsies in the LL group had some
CD68+ cells present and these levels were not altered by the
presence of ENL. The CD68+ cells were found in the infiltrate and
not in the epidermis in both cases and controls with ENL.
TNF-a. TNF-a protein was detected in 78% of skin biopsies
taken from definite leprosy cases at baseline (181/233). Across the
spectrum the BT, BL and LL cases had similar grades of staining
with 35–41% of biopsies having staining at grade 2–4. However,
only the BT cases had grade 4 staining with 7% cases staining at
grade 4; no BL or LL cases stained at grade 4. The TNF-a was
Figure 5. Skin stained for TGF-b. Skin showing TGF-b positive macrophages. IHC staining6100.
doi:10.1371/journal.pntd.0001327.g005
Table 4. Histological classification of nerve biopsies.
Bacterial Index
Classification N Mean SD
Tuberculoid leprosy (TT) in T1R* 2 0 0
Borderline tuberculoid (BT) leprosy 1 1.45 1.2
Borderline tuberculoid (BT) in T1R 20
Borderline lepromatous (BL) leprosy 6 3.5 1.5
Borderline lepromatous (BL) in T1R 21
Lepromatous leprosy (LL) / ENL** 7 4.4 .78
Indeterminate leprosy 2 0 0
No significant lesions (NSL) 9 0 0
Total 68
*T1R: Type 1 Reactions.
**ENL: Erythema Nodosum Leprosum.
doi:10.1371/journal.pntd.0001327.t004
Table 5. Comparison of Bacterial Index in skin and nerve
biopsies.
Bacterial Index in nerve biopsy
Bacterial Index in
skin biopsy 0 1–3 4–6 Total
0 16 10 4 30
1–3 3 11 9 23
4–6 1 2 10 13
Total 20 23 23 66
doi:10.1371/journal.pntd.0001327.t005
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located in macrophages and epithelioid cells within the granuloma
with no staining in the epidermis, dermis and only 7 cases with
staining detectable in the dermal nerves. Comparing the numbers
of patients by Ridley-Jopling category and the presence of TNF-a
in the macrophages a clear trend was seen with 81% of BT
macrophages staining for TNF-a compared with 69% BL and
64% LL. Very little TNF-a was detected in the biopsies of the
indeterminate/NSL group with 55% of the group showing
staining at grade 0, 30% at grade 1, 15% at grade 2 and 2% at
grade 3. This staining was present within the granuloma.
Detectable TNF-a in biopsies was significantly associated with
T1R (p,0.000) and the levels were similar in both BT T1R and
BL T1R patients. There was significantly more TNF-a in both
macrophages (p = 0.003) and granulomas (p#0.001) in biopsies
classed as being in T1R. TNF-a was not found in the dermis or the
dermal nerves in association with T1R. Using the presence of
TNF-a in the skin as a marker for reaction has a sensitivity of 21%
and a specificity of 96%. All the cases diagnosed histologically with
ENL had some staining for TNF-a, although the levels were quite
modest with six cases showing staining at only grades 1 and 3 and
one case at grades 2 and 3 respectively. The levels of TNF-a were
similar for ENL and non-ENL cases. The biopsies from patients
with ENL had 92% staining within the granuloma whilst those
from non-ENL cases had 53% (p= 0.015). Patients with ENL had
almost significantly higher (p = 0.052) amounts of TNF-a in their
macrophages. No TNF-a was detected in the epidermis or dermal
nerves.
iNOS. iNOS was detected in 78% (185/237) of skin biopsies
from established leprosy cases at baseline (Figure 5). The grade of
staining in biopsies from patients across the spectrum was similar.
Twelve percent of BT cases stained at level 3 compared with 4%
for BL and none for LL suggesting that this molecule is associated
with a well expressed cell mediated immunity response. iNOS was
detected in several locations - in the dermis (22.4%), granuloma
(43%) and sub-epidermal zone (28.6%). iNOS was found in
macrophages and epithelioid cells. Comparing iNOS levels in the
dermis and granuloma across the Ridley-Jopling spectrum shows a
clear trend with highest levels in the dermis and granuloma of BT
patients and lowest levels in the LL patients (skin iNOS dermis BT
47.7%, BL 36.4% and LL 15.9%; skin iNOS granuloma BT
45.3%, BL 39.0% and LL 32.1%; p,0.05). This is in accordance
with the role of iNOS as a mycobacterial killing agent. The levels
of staining for iNOS in the indeterminate group were very similar
to those found for TNF-a. Thirty-three percent of indeterminate
biopsies had iNOS staining in the dermis with only 12% showing
staining in the granuloma.
Significantly more iNOS was detected in biopsies from patients
with T1R (73% vs. 83%, p,0.001) and the grade of staining for
BT and BL in T1R patients was similar. There was significantly
more iNOS in the granulomas of patients in T1R (p#0.001).
iNOS was relatively absent from the dermis with only 15–20%
staining positive for iNOS, and absent from the epidermis and
dermal nerves. Macrophage staining levels of reactional skin
Table 6. Immuno-staining in nerve biopsies for CD68, TNF-a, TGF-b and iNOS.*
BT** BL*** LL{ No RR{ RR
Level of Staining % (N=21) % (N=27) % (N=7) % (N=15) % (N=43)
CD68 0 10 15 0 20 9
1 38 26 57 53 30
2 38 26 29 20 33
3 14 26 0 0 23
4 0 7 14 7 5
TNF-a 0 38 15 43 27 28
1 24 41 14 40 30
2 19 26 14 13 23
3 19 11 29 20 14
4 0 7 0 0 5
TGF-b 0 11 26 14 33 15
1 21 22 43 40 24
2 37 37 43 27 37
3 21 11 0 0 17
4 11 4 0 0 7
iNOS 0 24 26 0 27 28
1 48 41 71 40 44
2 29 30 29 33 26
3 0 4 0 0 2
4 0 0 0 0 0
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biopsies were non-significantly higher than non-reactional
(79.65% vs. 68.4%, not significant).
ENL. All patients diagnosed with ENL histologically had
some iNOS staining but the differences between ENL and non-
ENL patients were not significant. In the ENL group there was
some staining for iNOS in the dermis (28%) and some in the
granuloma (35%) but none in the epidermis or dermal nerves. One
hundred percent iNOS staining was observed in the macrophages
of ENL patients.
TGF-b. TGF-b was detected in 94% skin biopsies from
established leprosy cases at baseline (224/237; Figure 5). All types
of leprosy had low to high staining, but biopsies from BT patients
had significantly more TGF-b staining than from BL patients
(p = 0.05). TGF-b was found almost exclusively in macrophages
and epithelioid cells located in granulomas (92–100% biopsies)
and dermal nerve (7–12% biopsies). There were low levels of
TGF-b staining in the indeterminate/NSL group with 57% of this
group having staining at grade 1 and 14% at grade 2. In this group
the staining was located in the granuloma with none in the dermal
nerves.
T1R. TGF-b staining was significantly higher in reactional
skin biopsies (reactional vs. non reactional; p,0.001) and this
association was stronger for the BT patients (p,0.001) than
the BL patients (p = 0.01). TGF-b was located principally in
the reactional granuloma but there was no difference between
reactional and non-reactional cases in the amount of TGF-b in the
dermis or granuloma or the location. Significantly more TGF-b
was found in the dermal nerves of cases with T1R (p,0.001).
Using the presence of TGF-b in the skin as a marker for reaction
has a sensitivity of 44% and a specificity of 88%. All biopsies in the
LL group had some staining for TGF-b and there was no
difference between patients with or without ENL. No differences
were found for cell type or location of TGF-b between cases with
or without ENL.
S100. S100 staining corresponded inversely with the degree of
inflammation, with sections classified as NSL showing a higher
degree of staining and active BT and BL sections showing 0 or 1.
S100 stain in indeterminate lesions was helpful in localising the
nerve and the perineural cellular infiltrate. An active DTH in
reactional lesions was accompanied by nerve destruction and
consequent absence of S100 staining.
Nerve biopsies
Table 4 shows the Ridley-Jopling classification for 68 nerves.
When the skin and nerve classifications were compared we found
that in the three main groups, BT, BL and LL, there was 62%,
66% and 60% agreement between the skin and nerve classification
respectively. For the patients with a skin BT classification (n= 29)
Figure 6. Nerve stained for CD68 cells. Nerve showing CD68 positive macrophages. IHC staining640.
doi:10.1371/journal.pntd.0001327.g006
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their nerve biopsies showed two nerves classified as TT, five as BL
and one as indeterminate. The BL skin classification (n= 27)
showed two nerves classified as BT and four as LL. The skin LL
group had two nerves as BL classification. Table 5 shows the
comparison between the bacterial index in skin and nerve and that
the bacterial index was consistently higher in nerve than skin
biopsies. These data suggest that patients are less able to control the
mycobacterial infection in their nerves. Oedema was a notable
feature in nerves with a reactional pathology and wide separation of
axons was present with inflammatory cells and an increased
population of lymphocytes as focal collections or scattered in among
the inflammatory cells. In the nerves classified as TT T1R, the
epithelioid granuloma contained some Langhans giant cells and the
lymphocytes were present as a thick cuff around the granulomas.
Some nerves were clean with no evidence of intra or perineural
inflammation or acid fast bacilli and these were classified as NSL.
BT and BL nerve biopsies with evidence of reactional pathology
dominate this group with only one BT nerve not showing evidence
of T1R. There were also two TT nerves with evidence of
reactional pathology. Two nerves showed evidence of indetermi-
nate leprosy and nine nerves had no evidence of inflammation.
The bacterial index for each nerve group is given in Table 4 and
shows a higher bacterial index for each group in the nerve than in
the skin. Since there was only one nerve with evidence of ENL
pathology, comparison of the ENL versus non-ENL pathologies
could not be done. The nerve with ENL pathology showed modest
level of CD68 staining; iNOS staining at 1, TGF-b staining at 2
and no detectable TNF-a. The comparison for nerves with and
without T1R were all based on the BL group (six not in T1R, 21
with T1R).
CD68. Table 6 shows the level of staining for the immuno-
markers by leprosy type and reaction status in the nerve biopsies.
CD68 staining was detectable in 88% of nerve biopsies at baseline
(Figure 6). Higher staining levels were noted in the BL group with
33% of these biopsies staining at grade 3. Zero percent staining for
CD68 was located in the granuloma. Significantly higher numbers
of CD68 cells were present in nerves with T1R.
TNF-a. TNF-a was detected in 74% of all nerves with 62% of
BT in T1R (Figure 7). TNF-a was located in the granuloma and
nerves and almost exclusively found in macrophages. In the
lepromatous nerves TNF-a was found at grades 0–3 in macrophages.
iNOS. There was a variable staining pattern for iNOS in
nerves with 28% of TT and no staining in BT and BL. iNOS
staining was distributed almost equally between the nerve and the
granuloma and associated mainly with macrophages with some
staining associated with Schwann cells and axons.
TGF-b. TGF-b staining was found across the spectrum of
leprosy in nerves and was present at a higher level in BT nerves
Figure 7. Nerve stained for TNF-a. Nerve showing TNF-a positive macrophages. ICH staining640.
doi:10.1371/journal.pntd.0001327.g007
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(Figure 8). It was located in the granuloma associated almost
entirely with macrophages. TGF-b staining was not associated
with the presence of T1R.
S100. S100 staining is a marker of axonal integrity (Figure 9).
The level of S100 staining was higher in the NSL group than the
indeterminate group reflecting the normality of the nerve structure
in the NSL group. Forty-five percent of BT in T1R nerves had a
score of 0 or 1 on S100 staining which correlates with the
destructive process that is seen in these nerves.
The association between cytokine and marker staining levels (2–
4) in skin and nerve was compared (McNemar test) and levels of
CD68+ (p,0.01), TGF-b (p = 0.05) and iNOS (p,0.045) were
significantly associated, but not for TGF-b.
Discussion
The examination and comparison of clinical, histological and
immunological profiles in a new cohort of newly diagnosed
leprosy patients has yielded valuable insights and helped in
identification of potential cytokine markers for T1R. This study
is the largest prospective study that has combined clinical,
histological and immunological investigations on leprosy reac-
tions in a typical leprosy hospital in North India. Although all
the patients recruited had multiple leprosy skin and nerve lesions
and fulfilled field criteria for MB leprosy, on histological
examination the group comprised 42.6% BT, 27.5% BL, 9.4%
LL and 13% indeterminate. This indicates that the World
Health Organization MB classification is very heterogeneous
comprising at least four different Ridley-Jopling types. Of the BT
patients, 80% had no mycobacteria detectable either on slit skin
smears or in their biopsies. Only 5% of this cohort had highly
positive skin smears with a bacterial index of more than 4+. This
Indian cohort was dominated by bacteriologically negative but
immunologically active BT cases. This was borne out by the high
rate of reactions in this cohort with 52% of the BT patients
having T1R. The histological findings were typical for the
various Ridley-Jopling groups although the bacterial index was
lower than anticipated. We also demonstrated histological and
immunological differences between the various Ridley-Jopling
groups, so confirming that the Ridley-Jopling classification still
continues to be useful, especially when the immunological
aspects of leprosy are being investigated [31]. A recent study
of the histological diagnosis of T1R showed that oedema was one
of the most important features in the diagnosis of reactions [29].
This finding was also present here in both the skin and the nerve
biopsies. The ENL reactions were also typical with polymor-
phonuclear leukocyte infiltrate and oedema, often accompanied
by vasculitis and panniculitis.
Figure 8. Nerve stained for TGF-b. Nerve showing TGF-b positive macrophages. IHC staining6100.
doi:10.1371/journal.pntd.0001327.g008
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We have demonstrated significant new associations between
T1R and the presence of several cytokines. Levels of TNF-a,
TGF-b and iNOS when detected by immunohistochemistry were
all significantly increased in the skin T1R lesions. A similar pattern
of raised cytokine production was found in nerve T1R lesions with
the exception of iNOS. In both skin and nerves there were raised
numbers of macrophages as assessed by the CD68 marker. This is
the first time that iNOS and TGF-b have been found in skin T1R
lesions. The strong association of T1R and TGF-b in skin lesions
was not predicted since this molecule has both down- and up-
regulatory effects.
Previous work has shown that TNF-a is up-regulated in skin
and nerve biopsies in patients with T1R and this was confirmed in
this cohort [14]. We have also demonstrated that serum TNF
levels rise four to eight weeks before a T1R or nerve impairment
episode. These findings highlight the key role of TNF-a in leprosy
immunopathology. Future studies could look at the role of TNF in
inflammatory damage. It would also be interesting to quantify
TNF RNA levels and determine when they rise in relation to
leprosy reactions.
Our findings in relation to iNOS also complement earlier work
showing high levels of iNOS in tuberculoid and borderline patients
with T1R [16]. The biopsies in this cohort also show a clear trend
with high levels of iNOS in BT patients and very low, especially in
the dermis, in LL patients. It was interesting that 33% of the
patients with indeterminate leprosy had detectable iNOS in their
skin biopsy. This indicates that mycobacterial killing is going on in
this group as part of the evolving pathology even though the
granulomas are very small.
The levels of TGF-b were surprisingly high across the spectrum.
The staining levels for TGF-b were also higher than that found for
iNOS in the indeterminate group patients. The strong association
of TGF-b with dermal nerves was unexpected. TGF-b has a role
in controlling inflammation and maybe this is a neuro-protective
response to protect the dermal nerves from the intense inflam-
mation that accompanies leprosy.
The cytokine staining in the ENL biopsies did not show any
noteworthy patterns. It was surprising that higher levels of TNF-a
were not detected in the ENL lesions. However there were only
a few patients with ENL and some of these biopsies showed
only mild ENL histologically. The pathology of ENL requires
investigation with larger numbers of patients with better clinical
and pathological correlation. It is interesting that iNOS was
detected in all the biopsies with ENL. This may also be a marker
for mycobacterial killing.
It is striking that all the nerve biopsies showed evidence of acute
leprosy inflammation with oedema. There was good correlation
between the clinical diagnosis of acute nerve function loss and
Figure 9. Nerve stained with S100. Nerve showing S100 positive areas of staining of intact fibers and areas of absence of stain in segments of
nerve destruction. IHC staining620.
doi:10.1371/journal.pntd.0001327.g009
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pathological evidence of inflammation. This acute leprosy
inflammation was seen in biopsies from patients with all types of
Ridley-Jopling classification. This thus confirms our hypothesis
that the nerves would show a more severe pathology than skin with
more severe inflammation. This concurs with the model of leprosy
nerve damage that Scollard proposed in which he noted that
inflammation occurs at every stage of leprosy nerve damage [32].
Porichha et al has reported on the neural pathology in nerve
biopsies taken from patients with acute neuritis. Their findings
show both macrophage and epithelioid cell granulomas and
caseous necrosis was common in these nerves [33]. Because of the
absence of non-reactional nerves we were not able to compare
reactional with non-reactional nerve pathology.
The biopsies from the LL patients showed some immunological
activity with 64% of biopsies having some detectable TNF-a, some
(43%) TGF-b but only a few (29%) with detectable iNOS. This is
compatible with the LL lesions having some inflammation but
little anti-mycobacterial activity. With the panel of cytokines that
we used we cannot comment on the relative Th1/Th2 profiles of
cytokines produced within lesions because we were not able to
stain for cytokines such as IFN-c which are critical to making that
distinction.
Twenty percent of the skin biopsies from clinically determined
lesions showed either indeterminate leprosy or non-specific
inflammation. This was surprising because the patients had to
have at least five leprosy lesions and recruitment was done by
clinicians. The presence of 13% indeterminate cases in this cohort
shows that there are still many patients with early leprosy in North
India. These indeterminate cases have the potential to either self
heal or develop into established leprosy. Cytokines indicating
ongoing immunological activity and the capacity for mycobacterial
killing were detected in up to 33% of the indeterminate biopsies
and this therefore parallels the clinical skin signs. Six percent of the
skin biopsies showed non-specific inflammation which could be
either due to the biopsy missing the critical area, a sampling error,
or it could reflect a self-healing process.
One of the limitations of this study was that paraffin blocks were
used for cytokine detection, thus limiting the investigation because
monoclonal antibodies for detecting many cytokines cannot be
used in paraffin blocks.
This study has demonstrated that cytokines were significantly
associated with leprosy skin and nerve reactions and they may be
of use in diagnosing and assessing difficult reaction lesions. They
also indicate the complex immune-regulation in leprosy reactions
which requires further investigation.
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